|
Video: What is a Stock Split?
|
|
Palisade Bio is a biopharmaceutical company that develops therapeutics to protect the integrity of the intestinal barrier. Co.'s therapeutic candidate, LB1148, is an oral liquid formulation of the digestive enzyme inhibitor, tranexamic acid, used to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. LB1148 is formulated as an aqueous solution for oral (enteral) administration. The patented LB1148 formulation contains polyethylene glycol, carbohydrates, and electrolytes. The components of LB1148 are provided as dry powders for reconstitution in water prior to administration. According to our Palisade Bio stock split history records, Palisade Bio has had 3 splits. | |
|
Palisade Bio (PALI) has 3 splits in our Palisade Bio stock split history database. The first split for PALI took place on April 28, 2021. This was a 1 for 6 reverse split, meaning for each 6 shares of PALI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split. PALI's second split took place on November 16, 2022. This was a 1 for 50 reverse split, meaning for each 50 shares of PALI owned pre-split, the shareholder now owned 1 share. For example, a 166.666666666667 share position pre-split, became a 3.33333333333333 share position following the split. PALI's third split took place on April 08, 2024. This was a 1 for 15 reverse split, meaning for each 15 shares of PALI owned pre-split, the shareholder now owned 1 share. For example, a 3.33333333333333 share position pre-split, became a 0.222222222222222 share position following the split.
When a company such as Palisade Bio conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Palisade Bio stock split history from start to finish, an original position size of 1000 shares would have turned into 0.222222222222222 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Palisade Bio shares, starting with a $10,000 purchase of PALI, presented on a split-history-adjusted basis factoring in the complete Palisade Bio stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/06/2014 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$15,255.00 |
|
End price/share: |
$7.74 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.95% |
|
Average Annual Total Return: |
-53.17% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$5.07 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
04/28/2021 | 1 for 6 | 11/16/2022 | 1 for 50 | 04/08/2024 | 1 for 15 |
|
|